Ixorapeptide I and ixorapeptide II, bioactive peptides isolated from Ixora coccinea

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7354-7. doi: 10.1016/j.bmcl.2010.10.058. Epub 2010 Oct 19.

Abstract

Two novel derivatized peptides, designated as ixorapeptide I (1) and ixorapeptide II (2), in addition to 28 other known compounds, were isolated from the MeOH extract of Ixora coccinea using bioassay-guided fractionation. The structures of metabolites 1 and 2 were determined by interpretation of the spectroscopic data and Marfey's method. Compound 1 exhibited selective potency against Hep3B liver cancer cell line with an IC(50) value of 3.36 μg/mL, and compound 2 did not show notable cytotoxicity toward cancer cell lines but could inhibit superoxide anion generation and elastase release with IC(50) values of 0.21 and 0.27 μg/mL, respectively. Moreover, kaempferol and luteolin from this plant showed inhibition with IC(50) values of 3.55 and 2.56 μg/mL, respectively on platelet aggregation induced by collagen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Kaempferols / chemistry
  • Kaempferols / isolation & purification
  • Kaempferols / pharmacology
  • Luteolin / chemistry
  • Luteolin / isolation & purification
  • Luteolin / pharmacology
  • Magnetic Resonance Spectroscopy
  • Molecular Conformation
  • Pancreatic Elastase / metabolism
  • Peptides / chemistry*
  • Peptides / isolation & purification
  • Peptides / toxicity
  • Platelet Aggregation Inhibitors / chemistry
  • Platelet Aggregation Inhibitors / isolation & purification
  • Platelet Aggregation Inhibitors / pharmacology
  • Rubiaceae / chemistry
  • Rubiaceae / metabolism*
  • Structure-Activity Relationship
  • Superoxides / metabolism

Substances

  • Kaempferols
  • Peptides
  • Platelet Aggregation Inhibitors
  • ixorapeptide I
  • ixorapeptide II
  • Superoxides
  • kaempferol
  • Pancreatic Elastase
  • Luteolin